DE69624825T2 - Eintopfverfahren zur herstellung von 2-oxazolidinonderivate - Google Patents

Eintopfverfahren zur herstellung von 2-oxazolidinonderivate

Info

Publication number
DE69624825T2
DE69624825T2 DE69624825T DE69624825T DE69624825T2 DE 69624825 T2 DE69624825 T2 DE 69624825T2 DE 69624825 T DE69624825 T DE 69624825T DE 69624825 T DE69624825 T DE 69624825T DE 69624825 T2 DE69624825 T2 DE 69624825T2
Authority
DE
Germany
Prior art keywords
producing
pot process
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69624825T
Other languages
English (en)
Other versions
DE69624825D1 (de
Inventor
Rajnikant Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69624825D1 publication Critical patent/DE69624825D1/de
Publication of DE69624825T2 publication Critical patent/DE69624825T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DE69624825T 1995-08-07 1996-08-02 Eintopfverfahren zur herstellung von 2-oxazolidinonderivate Expired - Lifetime DE69624825T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516145.1A GB9516145D0 (en) 1995-08-07 1995-08-07 Improved chemical synthesis
PCT/GB1996/001885 WO1997006162A1 (en) 1995-08-07 1996-08-02 One pot synthesis of 2-oxazolidinone derivatives

Publications (2)

Publication Number Publication Date
DE69624825D1 DE69624825D1 (de) 2002-12-19
DE69624825T2 true DE69624825T2 (de) 2003-09-04

Family

ID=10778867

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69624825T Expired - Lifetime DE69624825T2 (de) 1995-08-07 1996-08-02 Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE69636107T Expired - Lifetime DE69636107T2 (de) 1995-08-07 1996-08-02 Verfahren zur Reinigung von (S)-4-((dimethylamino)ethyl)-1H-Indol-5yl)-methyl)-2-Oxazolidinone

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69636107T Expired - Lifetime DE69636107T2 (de) 1995-08-07 1996-08-02 Verfahren zur Reinigung von (S)-4-((dimethylamino)ethyl)-1H-Indol-5yl)-methyl)-2-Oxazolidinone

Country Status (34)

Country Link
US (2) US6084103A (de)
EP (2) EP1227095B1 (de)
JP (6) JP3729503B2 (de)
KR (1) KR100670704B1 (de)
CN (3) CN1092657C (de)
AR (2) AR006515A1 (de)
AT (2) ATE325121T1 (de)
AU (1) AU718413B2 (de)
BR (1) BR9609830A (de)
CA (2) CA2572508C (de)
CZ (2) CZ293050B6 (de)
DE (2) DE69624825T2 (de)
DK (2) DK1227095T3 (de)
ES (2) ES2185790T3 (de)
GB (1) GB9516145D0 (de)
HK (2) HK1009129A1 (de)
HU (1) HU229966B1 (de)
IL (4) IL123171A (de)
IN (2) IN185148B (de)
MX (1) MX9801044A (de)
MY (1) MY117571A (de)
NO (2) NO311690B1 (de)
NZ (1) NZ315040A (de)
PL (1) PL188805B1 (de)
PT (2) PT1227095E (de)
RO (2) RO121816B1 (de)
RU (1) RU2167875C2 (de)
SI (2) SI0843672T1 (de)
SK (1) SK285052B6 (de)
TR (1) TR199800182T1 (de)
TW (1) TW358811B (de)
UA (1) UA53625C2 (de)
WO (1) WO1997006162A1 (de)
ZA (1) ZA966711B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004088A1 (fr) * 1999-07-09 2001-01-18 Chugai Seiyaku Kabushiki Kaisha Procede de preparation de derives d'amiline
ES2204302B2 (es) 2002-08-07 2005-03-01 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
EP1711493A2 (de) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Kristalline formen von zolmitriptan
WO2006055964A2 (en) * 2004-11-19 2006-05-26 Teva Pharmaceutical Industries Ltd. Zolmitriptan crystal forms
EP1942193A4 (de) 2005-08-25 2010-10-27 Ube Industries VERFAHREN ZUR HERSTELLUNG OPTISCH AKTIVER (S ODER R)-a- AMINOSÄURE ODER EINES OPTISCH AKTIVEN (S ODER R) -a-AMINOSÄUREESTERS
ATE510836T1 (de) * 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
WO2008007390A2 (en) * 2006-07-10 2008-01-17 Natco Pharma Limited An improved process for purification of zolmitriptan
WO2008018090A2 (en) * 2006-08-09 2008-02-14 Matrix Laboratories Ltd An improved process for the preparation of zolmitriptan
CZ2007158A3 (cs) * 2007-02-26 2008-10-22 Zentiva, A. S. Zpusob prípravy zolmitriptanu
CZ301538B6 (cs) 2007-02-26 2010-04-07 Zentiva, A. S. Zpusob prípravy zolmitriptanu
EP2201003A1 (de) * 2007-10-03 2010-06-30 Generics Ýuk¨Limited Verfahren zur herstellung von zolmitriptan, salzen und solvaten davon
CN101230047B (zh) * 2008-02-04 2010-08-04 江苏中威药业有限公司 一种4-取代手性噁唑烷酮类化合物的制备方法
EP2387993B1 (de) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Zolmitriptan-Tabletten und Herstellungsverfahren dafür
CN101948443B (zh) * 2010-08-17 2012-08-22 河南师范大学 一种简单、高效合成4-取代噁唑烷酮衍生物的方法
WO2012135615A2 (en) 2011-03-30 2012-10-04 Brown University Enopeptins, uses thereof, and methods of synthesis thereto
WO2013057739A2 (en) * 2011-09-02 2013-04-25 Emcure Pharmaceuticals Limited An improved process for preparation of zolmitriptan
CN102964270B (zh) * 2012-11-21 2015-01-07 合肥星宇化学有限责任公司 一种亚硫酸钠还原重氮盐合成肼的方法
CN103275075B (zh) * 2013-06-24 2015-01-07 成都天台山制药有限公司 佐米曲普坦及其制备方法
WO2016037072A2 (en) * 2014-09-04 2016-03-10 Brown University Enopeptin analogas and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
SK281621B6 (sk) * 1990-06-07 2001-05-10 Astrazeneca Ab Indolové deriváty, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists

Also Published As

Publication number Publication date
ES2185790T3 (es) 2003-05-01
CA2227039C (en) 2007-12-04
CZ301603B6 (cs) 2010-04-28
IN185148B (de) 2000-11-25
JP4634286B2 (ja) 2011-02-16
EP0843672B1 (de) 2002-11-13
SK285052B6 (sk) 2006-05-04
SK15498A3 (en) 1998-06-03
HK1047094B (zh) 2006-10-13
IL148030A (en) 2010-05-17
SI1227095T1 (sl) 2006-08-31
CA2572508C (en) 2010-03-30
CN1244579C (zh) 2006-03-08
KR100670704B1 (ko) 2007-07-11
WO1997006162A1 (en) 1997-02-20
EP0843672A1 (de) 1998-05-27
UA53625C2 (uk) 2003-02-17
PT843672E (pt) 2003-03-31
TW358811B (en) 1999-05-21
MY117571A (en) 2004-07-31
RU2167875C2 (ru) 2001-05-27
KR19990036165A (ko) 1999-05-25
NO311691B1 (no) 2002-01-07
NO980522L (no) 1998-02-06
CA2572508A1 (en) 1997-02-20
AU718413B2 (en) 2000-04-13
CN1403455A (zh) 2003-03-19
JP3729503B2 (ja) 2005-12-21
EP1227095B1 (de) 2006-05-03
GB9516145D0 (en) 1995-10-04
JP2002037786A (ja) 2002-02-06
JP3739678B2 (ja) 2006-01-25
IL156733A (en) 2007-07-04
US6160123A (en) 2000-12-12
IL156733A0 (en) 2004-02-08
PL188805B1 (pl) 2005-04-29
US6084103A (en) 2000-07-04
AR006515A1 (es) 1999-09-08
JPH11513023A (ja) 1999-11-09
IL123171A0 (en) 1998-09-24
ATE325121T1 (de) 2006-06-15
IN189756B (de) 2003-04-19
DK1227095T3 (da) 2006-07-31
DE69636107D1 (de) 2006-06-08
NZ315040A (en) 2000-01-28
CN1317480A (zh) 2001-10-17
HU229966B1 (hu) 2015-03-30
HK1009129A1 (en) 1999-05-28
IL148030A0 (en) 2002-09-12
HUP9900188A2 (hu) 1999-05-28
SI0843672T1 (en) 2003-04-30
HK1047094A1 (en) 2003-02-07
RO121816B1 (ro) 2008-05-30
ATE227723T1 (de) 2002-11-15
MX9801044A (es) 1998-05-31
CZ293050B6 (cs) 2004-01-14
CN1142904C (zh) 2004-03-24
DK0843672T3 (da) 2003-02-17
AU6663496A (en) 1997-03-05
NO980522D0 (no) 1998-02-06
DE69624825D1 (de) 2002-12-19
AR046236A2 (es) 2005-11-30
JP2002308858A (ja) 2002-10-23
BR9609830A (pt) 1999-03-09
JP2002097178A (ja) 2002-04-02
CA2227039A1 (en) 1997-02-20
JP2006077025A (ja) 2006-03-23
IL123171A (en) 2003-10-31
RO119618B1 (ro) 2005-01-28
CZ35298A3 (cs) 1998-06-17
PL324881A1 (en) 1998-06-22
DE69636107T2 (de) 2007-05-03
CN1201460A (zh) 1998-12-09
EP1227095A3 (de) 2003-11-19
NO311690B1 (no) 2002-01-07
PT1227095E (pt) 2006-08-31
ES2261545T3 (es) 2006-11-16
ZA966711B (en) 1997-02-18
EP1227095A2 (de) 2002-07-31
NO20005187D0 (no) 2000-10-16
TR199800182T1 (xx) 1998-05-21
NO20005187L (no) 1998-02-06
CN1092657C (zh) 2002-10-16
HUP9900188A3 (en) 1999-11-29
JP2006225406A (ja) 2006-08-31

Similar Documents

Publication Publication Date Title
DE69624825D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE69620461D1 (de) Verfahren zur herstellung von 1,1,1,3,3,-pentafluoropropanen
ATE309266T1 (de) Prozess zur herstellung bestimmter aza- zyklohexapeptide
DE69618476D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE69502384D1 (de) Prozess zur herstellung von polyarylenetherketonen
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE59603916D1 (de) Verfahren zur Herstellung von Imidazo-Benzodiazepin-Derivaten
DE69625253T2 (de) Verfahren zur Herstellung von Imidazochinazolinon-Derivaten
DE69628203D1 (de) Verfahren zur herstellung von phenylimidazolin-derivaten
DE69635421T2 (de) Verfahren zur herstellung von 2-chlorthiazolderivaten
DE69604875T2 (de) Verfahren zur Herstellung von Cyclopentadienylderivaten
DE69603261D1 (de) Verfahren zur herstellung von 1,2-benzisothiazolonen
DE69611331T2 (de) Verfahren zur Herstellung von S-Phenyl-L-Cystein
DE69631154D1 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
DE69603243T2 (de) Verfahren zur Herstellung von Ethenylamiden
DE69611380D1 (de) Verfahren zur herstellung von dioxoazabiclohexanderivaten
DE69613306D1 (de) Vorrichtung zur Herstellung von Kristallen
DE69617988T2 (de) Verfahren zur herstellung halogenierter cyclopropan-derivate
DE59601796D1 (de) Verfahren zur Herstellung von Hydroxymethyl-cyclopropan
DE29515391U1 (de) Vorrichtung zur Herstellung von Borstenwaren
DE59604455D1 (de) Verfahren zur Herstellung von racemischen Amino-Derivaten
DE59605690D1 (de) Verfahren zur Herstellung standfester Tüten
DE29507545U1 (de) Vorrichtung zur Herstellung von Falten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition